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1. Introduction 
cr-L-Fucosyltransferases have been detected in sol- 
uble form in human milk [ 121, serum [3,4] and as 
membrane-bound enzymes in human red cell ghosts 
[S], lymphocytes and platelets [6], stomach mucosa 
and submaxillary glands [7], bone marrow [8] and 
kidney [9]. 
The H-gene-specified enzyme, 2_ol-L-fucosyltrans- 
ferase [lo] and the Le-gene-specified enzyme, 4++L- 
fucosyltransferase [ 11 ,121 are direct products of H 
and Le blood group genes, respectively. Both enzymes 
catalyze the transfer of L-fucose in e-linkage to the 
C-2 position of terminal non-reducing /3-D-galactosyl 
residue and to the C4 position of sub-terminal N- 
acetyl-D-glucosaminyl residue, respectively. 
The 3_ol-L-fucosyltransferase catalyses the transfer 
of L-fucose in a a-linkage to C-3 position of subtermi- 
nal N-acetyl-D-glucosamine or D-glucose residue 
[ 1,3,7]. It has not been described as being like a spec- 
ified blood group enzyme, although it is involved in 
the synthesis of related substances. 
The three enzymes have been described in milk 
[ 1 ,13 ,141. While the 2 - and 3+-L-fucosyltransferases 
have been found in sera [3,4,15], the 4a-L-fucosyl- 
transferase has not yet been detected in adult human 
sera from individuals carrying the Le gene [3]. The 
2a-L-fucosyltransferase activity failed to appear in 
Bombay, Ah, Bh, Hz phenotypes [3,5,16]. The 3a-L- 
fucosyltransferase activity was identified in all individ- 
uals. In [ 17 ,181 fucosyltransferase activities were 
reported to increase in cancer patients; the elevated 
activities could be an indicator of malignancy. 
Here we report the electrofocusing properties of 
these transferases from human milk and sera. It was 
of interest to determine if the soluble transferases 
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having the same specificity (2 or 3++L-fucosyltrans- 
ferase activity) present in different molecular forms 
in 2 compartments of the organism. 
2. Materials and methods 
2 .l . Enzyme substrates 
GDP-L-[U-14C]fucose was purchased from the 
Radiochemical Centre (Amersham) (118 Ci/mol) and 
from New England Nuclear (230 Ci/mol) and used in 
2% ethanolic solution. Phenyl&D-galactopyranoside 
was obtained from Koch-Light and lacto-N-biose I 
from Sefochem (Israel). N-Acetyllactosamine and 
2’-fucosyl-N-acetyllactosamine, chemically synthe- 
sized, were a gift from Professor Singy (OrlCans). 
2.2. Sources of fucosyltransferases 
Fresh human milk was purchased from Lactarium 
(Ecole de PuCriculture, boulevard Brune, Paris). Milk 
was defatted by centrifugation 30 min, 10 000 X g, 
4”C, faltered on a G-50 Sephadex column pre-equili- 
brated with 7.7 mM NaCl and then lyoph&sed. 
Another lyophilised preparation, gift of H. Schenkel 
Brunner, was obtained according to [ 141. 
Sera were stored at -20°C until use, then precipi- 
tated at 40% saturation of ammonium sulfate and 
desalted by gel filtration on a G-50 Sephadex column 
equilibrated in 0.05 mM Tris-HCl buffer (PH 7.2). 
2.3. Isoelectric focusing 
Isoelectric focusing was performed by the standard 
method [19], either on an LKB 8101 (110 ml) appa- 
ratus or, in one case, on a laboratory-made column 
(170 ml). 
The gradient (sucrose: 4-48%, 2% ampholytes 
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(PH 3.5 -10)) was prefocused for 60 h at 4°C. Lyoph- 
ilised samples (20 mg) were solubilised in a small frac- 
tion of the gradient and then introduced into the col- 
umn. Either crude extracts or ammonium sulfate 
precipitated samples (2-3 ml) were loaded after adjust- 
ment of their density. Electrofocusing was continued 
for 15-20 h with a starting power of 1 W (-500 V, 
-2 mA). The final power was 3 W with 1000 V as a 
maximum voltage. After collecting fractions of 2 ml 
or 4 ml into bovine albumin (final cont. OS%), pH 
was measured at 4°C. Each fraction was filtered on 
G-50 Sephadex columns preequilibrated in Tris-HCl, 
0.01 M (pH 7.2) buffer or 7.7 mM NaCl for serum and 
0.05 M Tris-HCI, @H 7.2), 1 mM glutathione, or 
7.7 mM NaCl for milk. Fractions were then concen- 
trated in batch with G-25 Sephadex (coarse) or lyoph- 
ilised. Lyophilised fractions were solubilised in 400 ~1 
distilled water before use. 
2.4. Assays of fucosyltransferase activities 
The 2a-L-fucosyltransferase activity was tested on 
phenyl@D-galactoside as substrate [20]. The reaction 
mixture was: 30 ~1 sample; phenyl-fl-D-galactoside 
32mM in 0.05 mMMESbuffer,0.96,umol;Tris-HCl, 
(pH 7.2), 3.6 ymol; MgC12, 0.6 pmol; ATP, 0.6 pmol; 
GDP [14C]fuc, 2 nmol; in 85 yl final vol. After incu- 
bation for 72 h at 37”C, the mixture was submitted to 
descending chromatography, carried out on Whatman 
40 paper, in ethyl acetate-pyridine-water (10:4:3, 
by vol.) for 6 h. 
The 3a-L-fucosyltransferase activity was tested on 
N-acetyllactosamine or 2’-fucosyl-N-acetyllactosamine 
as acceptor, while the 4a!-L-fucosyltransferase was 
tested on lacto-N-Biose I. The incubation mixture con- 
tained the same reagents as above, except the phenyl- 
fl-D-galactoside which was-substituted by lacto-N- 
Biose I. The final volume was 60 d. After incubation 
at 37’C for 72 h, samples were electrophoresed in 
0.1 M (pH 3.5) ammonium formate buffer (Whatman 
40 paper; 2000 V, 2 h). The neutral substances 
remaining at the origin were separated by descending 
chromatography in pyridine-ethyl acetate-acetic 
acid-water (5 :5 : 1:3, by vol.). Specific products were 
characterised by their migration with regard to stan- 
dard sugars (lactose or fucose),and compared to oligo- 
saccharides of established structures. 
The fucosidasic activity was tested in the same con- 
ditions as for transferase; the acceptor substrate was 
substituted by 5 ~1 [ 14C] Fuc-Gal-phenyl or [ 14C]- 
Fuc-Gal 01 + 3 GlNac (6000 cpm and 7500 cpm, 
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respectively) and GDP [14C]fuc by distilled water. 
These two 14C-labelled substrates were obtained by 
elution. 
3. Results and discussion 
Electrofocusingstudies were carried out on sera from 
different blood groups. An example of the isoelectro- 
focusing pattern for an AB serum is shown in fig.1. 
The 2a-L-fucosyltransferase activity tested with 
phenyl+D-galactoside as substrate focused at an aver- 
age of pH 4.7 for the 5 sera studied. Lyophilisation of 
samples,insteadofconcentration withG-25 Sephadex 
increased clearly the yield of recovery of 2+L-fucosyl- 
transferase activity (m-0.5-30%). With this improve- 
ment, it was repeatedly found that only one peak of 
enzyme activity exists, at acidic pH. TheH-gene-speci- 
Fig.1. Isoelectrofocusing profile of AB serum. Fractions (4 ml) 
were lyophilised, then solubilised in 400 ~1 distilled H,O and 
tested for 2+L-fucosyltransferase activity with phenylj3-D- 
galactoside (0) and 3*-L-fucosyltransferase ctivity with 
2’-fucosyl_Nacetyllactosamine (*). Enzyme activities are 
expressed in cpm of radiolabelled fucose incorporated into 
appropriate acceptor; (0) released [‘T]fucose. 
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fied enzyme from normal serum presents only one 
molecular form with an isoelectric point of 4.7. 
The 34-L-fucosyltransferase was testedonllr-acetyl- 
lactosamine for two sera and on 2’-fucosyl-N-acetyl- 
lactosamine for one serum (fig.1). This enzyme focused 
at pH 5 .O on average. 
The pI-values, 4.7 for H-gene-specified enzyme and 
5 .O for 3a-L-fucosyltransferase are lower than the iso- 
electric points obtained in [2 1,221: 5 .l and 5.6 for 
normal serum, respectively. However, the difference 
observed could be due to the method used: isoelectro- 
focusing carried out on flat bed containing Ultrodex, 
over pH 4-6. In our experiment (see fig. l), despite 
their overlapping activities, the 2 and 3a-L-fucosyl- 
transferases also appear as being two different enzymes 
in serum. Nevertheless, the isoelectrofocusing method 
is not efficient in separating 2- and 34-L-transferases 
from each other. 
The electrofocusing pattern of 3+L-fucosyltrans- 
ferase and 4iu-L-fucosyltransferase from 20 mg milk 
protein prepared as in [ 141 is shown in fig.2. The 3a- 
L-fucosyltransferase activity appears in 3 peaks with 
PI-values of 6.2,7 .O and 9 .l . The patterns obtained 
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Fig.2. Isoelectric focusing profile of milk. Fractions (2 ml) 
were concentrated in batch with G-25 Sephadex (coarse). 3_or- 
L-fucosyltransferase activity was tested with N-acetyllactos- 
amine (*) and 4ilr-L-fucosyltransferase activity with lacto-N- 
Biose I (m). Enzyme activities are expressed in cpm of radio- 
labelled fucose incorporated into appropriate acceptor; (o) 
released [“C]fucose. 
above may result from degradation or aggregation of 
a single enzyme occurring either in vivo after the 
secretion process (soluble unstable molecule) or in 
vitro; e.g., by sialic acid release. However, the 3 appar- 
ent forms may be 3 isozymes. A variety of mecha- 
nisms is available for generating molecular multiplicity 
of one enzyme. In the cell of origin a gene can be 
duplicated and every gene can then diverge by muta- 
tion to produce a modified version of the original 
enzyme. After differentiation, each isozyme form can 
be expressed in a certain tissue, while another form 
can be expressed in another tissue [23]. So the single 
form with a p1 of 5 .O in serum, which differs from 
the p1 of multiple molecular forms in milk, can be 
explained. Isozymes can, however, result from epi- 
genie phenomena. The multiple enzymes can get an 
identical primary structure (encoded by the same 
gene), but differ in other respects, such as different 
subsequent modifications in different tissues. For 
example, if they are glycoproteins, they may vary in 
the nature of the carbohydrate side chains. 
The 2+L-fucosyltransferase in milk does not show 
up. Its activity appears in traces in crude milk from 
secretor individuals, relative to the 3- and 4-o-L-fuco- 
syltransferase activities. With phenylQ-D-galactoside 
as acceptor, it is very low or hardly detectable. Lac- 
tose is a better acceptor for the 2*-L-fucosyltransfer- 
ase activity but using this substrate, the 3iy-L-fucosyl- 
transferase activity also gave a product which is not 
easily separated from the H hapten. Attempts to con- 
centrate the 2a!-L-fucosyltransferase activity failed 
because of its instability. 
The &gene-specified 44-L-fucosyltransferase 
shows one peak with p1 value of 9.1. It seems that a 
single form of this enzyme is present in milk. As stated, 
the Le-gene-specified enzyme is absent in serum. 
In all the experiments, in milk and serum, degrada- 
tion with production of fucose competes with trans- 
ferase activity. The released [ 14C] fucose can be due 
to either fucose hydrolase, pyrophosphatase and phos- 
phatase activities or fucosidase activity acting directly 
on the products formed by each specific enzyme; it 
can also be due to chemical hydrolysis. However, the 
phenomena differ in serum or milk. 
After focusing in the presence of serum, the 
released [ 14C]fucose was seen all over the pH gradient. 
In [24] fucosidasic activity was detected in serum 
only between pH 4.9-6.4; activity was tested with 
specific substrate, the 4-methylumbelliferyl+L-fuco- 
side. Our results could be induced by focusing at vari- 
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ous pH of all the above types of enzymes, which 
release [‘4C]fucose. Chemical degradation could also 
arise, although the same experimental conditions for 
milk studies do not induce the same degradation. 
Nevertheless, 2- and 3*-L-fucosyltransferase activities 
in serum were easily detectable. 
In milk, fucose was mainly released at pH 4.0-5.5 
(see tig.2). In the other part of the gradient [14C]- 
fucose was low and corresponded to normal decom- 
positionof GDP [i4C]fucose. The weak 2+L-fucosyl- 
transferase activity in crude milk preparation, before 
focusing, is always associated with a strong fucosidasic 
activity. Attempts to decrease the second activity and 
increase the first failed; the two activities appear to be 
linked as is also suggested by 1251. It could be possible 
that these two activities are supported by the same 
molecular species. It is feasible that, after isoelectro- 
focusing, the weak andunstable 2+L-fucosyltransfer- 
ase activity is lost, whereas fucosidase activity is pre- 
served and focused at pH 4.0-5 5. In order to prove 
if fucosidase activity corresponds to the degradation 
of the product formed by transferase activity, [ 14Cf- 
Fuc (~1 + 2 Gal-phenyl and [ 14C] Fuc al + 2 Gal 
01 -+ 3 GlNac were tested as substrates in all the frac- 
tions of isoelectrofocusing, under the same conditions 
of transferase activity; [ 14C ]fucose was not released. 
Con~quently, we suppose that it is a GDP fucose 
hydrolase activity, which could be associated to the 
transferase activity. This hypothesis has been put for- 
ward in [25] where 24-L-fucosyltransferase has been 
purified from porcine submaxillary gland. 
In summary: we have found 1 form of 2iu-L-fuco- 
syltransferase in serum (PI 4.7); 4 forms of 34-L-fuco- 
syltransferase, with 1 in serum (PI 5 -0) and 3 differ- 
ent ones in milk (PI 6.2,7.0,9.1); and 1 form of 
4+L-fucosyltransferase in milk (PI 9.1). 
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